Covidien Announces Five-Year Results from the ClosureFast™ Long-Term European Multi-Center Study in Patients with Lower Limb Venous Disease Study Demonstrates Long-Term Durability of the ClosureFast™ ...

"Our study found the ratio of efficacy to side effects of the VNUS ClosureFAST catheter to be superior to any previous endovenous ablation device," said Dr. Proebstle. "In 223 cases where the ...

SAN JOSE, Calif., Aug. 14 VNUS(R) MedicalTechnologies, Inc. (Nasdaq: VNUS), a worldwide leader in medical devices forthe minimally invasive treatment of venous reflux disease, is enjoying ...

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, today announced that more than 200,000 ClosureFast ® ...

A less painful procedure is available locally for area residents among the hundreds of thousands of Americans suffering from severe varicose veins. Dr. Edward Lopez, general surgeon on staff at ...

DUBLIN - Feb. 10, 2015 - The ClosureFast(TM) endovenous radiofrequency ablation catheter from Medtronic plc (MDT) is safe and effective for the treatment of chronic venous insufficiency (CVI) over ...

Co announces the recent launch of the VNUS ClosureFAST catheter, a major advance in the treatment of the underlying cause of varicose veins. ClosureFAST is an endovenous radiofrequency ablation ...

Hillview resident Gerri Cooper-Cox is wearing shorts this summer for the first time in 10 years. That's how long it's been since she developed varicose veins in her right calf that made her ...

September 26, 2006 -- The US Food and Drug Administration (FDA) has granted a clinical laboratory improvement amendment waiver for a portable lead test, thereby improving its availability and access, ...

Study Demonstrates Long-Term Durability of the ClosureFast™ Radiofrequency Ablation System for Treatment of Chronic Venous Insufficiency MANSFIELD, Mass.-- Covidien, a leading global provider of ...